Evidence map›Paper›PMID 9811896›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

c-Myc target gene specificity is determined by a post-DNAbinding mechanism.

K E Boyd, J Wells, J Gutman, S M Bartley, P J Farnham

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 278 citations in OpenAlex.

  1. Article
  2. Examining NF-κB genomic interactions by ChIP-seq and CUT&Tag.bioRxiv : the preprint server for biology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

K E BoydMcArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison, WI 53706, USA.
J Wells
J Gutman
S M Bartley
P J Farnham
University of Wisconsin–Madison · US

Funding

Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
TRANSCRIPTIONAL REGULATION OF GROWTH-RELATED GENESR01CA045240 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI FARNHAM, PEGGY J · 1992 to 2011
$3.4M
STOREROOM AND MATERIALS ACQUISITION LABORATORYP30CA007175 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI PITOT, JR., HENRY C · 1985 to 2000
$2.4M
MOLECULAR MECHS REGULATING CANCER CELL PROLIFERATIONT32CA009681 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI HOFFMANN, F. MICHAEL · 1993 to 2007
$1.9M
TRANSCRIPTIONAL REGULATION OF GROWTH-RELATED GENESR29CA045240 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI FARNHAM, PEGGY J · 1987 to 1991
–
NCI NIH HHS CA07175NCI NIH HHS CA09135NCI NIH HHS CA45240NCI NIH HHS R01 CA045240NCI NIH HHS T32 CA009135NCI NIH HHS T32 CA009681
6 · The paper itself

Abstract

Uncertainty as to which member of a family of DNA-binding transcription factors regulates a specific promoter in intact cells is a problem common to many investigators. Determining target gene specificity requires both an analysis of protein binding to the endogenous promoter as well as a characterization of the functional consequences of transcription factor binding. By using a formaldehyde crosslinking procedure and Gal4 fusion proteins, we have analyzed the timing and functional consequences of binding of Myc and upstream stimulatory factor (USF)1 to endogenous cellular genes. We demonstrate that the endogenous cad promoter can be immunoprecipitated with antibodies against Myc and USF1. We further demonstrate that although both Myc and USF1 can bind to cad, the cad promoter can respond only to the Myc transactivation domain. We also show that the amount of Myc bound to the cad promoter fluctuates in a growth-dependent manner. Thus, our data analyzing both DNA binding and promoter activity in intact cells suggest that cad is a Myc target gene. In addition, we show that Myc binding can occur at many sites in vivo but that the position of the binding site determines the functional consequences of this binding. Our data indicate that a post-DNA-binding mechanism determines Myc target gene specificity. Importantly, we have demonstrated the feasibility of analyzing the binding of site-specific transcription factors in vivo to single copy mammalian genes.

Indexed as

Genes, mycGene Targeting3T3 CellsAnimalsBinding SitesDNADNA-Binding ProteinsMiceMolecular Sequence DataTranscriptional ActivationDNADNA-Binding Proteins

Identifiers

PMID9811896
PMCPMC24949
OpenAlexW1974279777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.